There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is ...

This enables Sanofi to assume lead commercial responsibilities for Novavax's COVID-19 vaccine beginning with the '25-'26 vaccination season. In addition to COVID vaccine, the deal gives Sanofi ...

Now Trump wants to end its ‘woke AI’ efforts Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants ...

If that’s the new policy, “you’d always be doing clinical trials and you’d never have a vaccine that was up to date.” The Novavax vaccine, which originally showed effectiveness in a ...